Jansen Valerie Malyvanh 4
4 · Elevation Oncology, Inc. · Filed Feb 20, 2024
Insider Transaction Report
Form 4
Jansen Valerie Malyvanh
CHIEF MEDICAL OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-02-15+225,000→ 225,000 totalExercise: $2.77Exp: 2034-02-14→ Common Stock (225,000 underlying) - Award
Restricted Stock Unit
2024-02-15+70,000→ 70,000 total→ Common Stock (70,000 underlying)
Footnotes (4)
- [F1]The stock option vests as to 25% of the total shares on February 15, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the RSUs vest on February 15, 2025, and the remainder will vest as to 1/16 of the total RSUs quarterly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.
- [F4]The RSUs do not expire; they either vest or are canceled prior to the vesting date.